| Trial Identifier: | 213406 |
| Sponsor: | GlaxoSmithKline |
| Start Date: | October 2020 |
| Primary Completion Date: | April 2025 |
| Study Completion Date: | April 2025 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Czech Republic | Brno, Czech Republic, 62500 |
| Czech Republic | Praha, Czech Republic, 150 06 |
| France | Lyon, France, 69373 |
| France | Marseille, France, 13005 |
| France | Paris, France, 75248 |
| France | Villejuif, France, 94805 |
| Spain | Barcelona, Spain, 08035 |
| Spain | Barcelona, Spain, 08950 |
| Spain | Madrid, Spain, 28009 |
| Spain | Madrid, Spain, 28046 |
| Spain | Valencia, Spain, 46026 |
| United Kingdom | Birmingham, United Kingdom, B4 6NH |
| United Kingdom | Glasgow, United Kingdom, G51 4TF |
| United Kingdom | London, United Kingdom, NW1 2PG |
| United Kingdom | Sutton, United Kingdom, SM2 5PT |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company